The dorsolateral striatum mediates habit formation, which is expedited by exposure to alcohol. Across species, alcohol exposure disinhibits the DLS by dampening GABAergic transmission onto this structure's principal medium spiny projection neurons (MSNs), providing a potential mechanistic basis for habitual alcohol drinking. However, the molecular and circuit components underlying this disinhibition remain unknown. To examine this, we used a combination of whole-cell patch-clamp recordings and optogenetics to demonstrate that ethanol potently depresses both MSN-and fast-spiking interneuron (FSI)-MSN GABAergic synaptic transmission in the DLS. Concentrating on the powerfully inhibitory FSI-MSN synapse, we further show that acute exposure of ethanol (50 mM) to striatal slices activates delta opioid receptors that reside on FSI axon terminals and negatively couple to adenylyl cyclase to induce a long-term depression of GABA release onto both direct and indirect pathway MSNs. These findings elucidate a mechanism through which ethanol may globally disinhibit the DLS.
INTRODUCTION
The dorsolateral subregion of the striatum (DLS) mediates habits, such as ethanol (EtOH) consumption in latestage alcoholism, while the dorsomedial subregion (DMS) mediates goal-directed action strategies . Animals with DMS lesions only express habit response strategies, while those with lesions to the DLS exclusively use a goal-directed action strategy (Yin et al, 2004 (Yin et al, , 2005 . Thus, the relative output of one striatal subregion over the other dictates the expression of its cognate action strategy. Animals previously exposed to EtOH respond habitually for EtOH at earlier time points than non-addictive substances such as food pellets or sucrose solution (Dickinson et al, 2002; Corbit et al, 2012) . In addition, EtOH-drinking rats form habits for sucrose solution more rapidly than EtOH-naive animals (Corbit et al, 2012) . A mechanistic understanding of how EtOH may interact with the DLS to achieve this is lacking.
The effects of acute and chronic EtOH exposure on dorsal striatal function provide clues as to how this drug mediates a possible global activation of the DLS. Blomeley et al (2011) , as well as Wilcox et al (2014) demonstrated that acute EtOH exposure to striatal slices depresses inhibitory synaptic transmission onto principal medium spiny neurons (MSNs) of the DLS. This acute EtOH effect may persist in chronic drinking models as chronic EtOH consumption in rodents and non-human primates depresses GABA release onto MSNs of the DLS/putamen (Cuzon Carlson et al, 2011; Wilcox et al, 2014) . Despite the mounting evidence of EtOHinduced disinhibition of DLS MSNs, the microcircuit and molecular determinants of EtOH-induced MSN disinhibition remain unknown.
MSNs receive a majority of inhibitory inputs from neighboring MSNs and parvalbumin (PV)-containing fastspiking interneurons (FSIs; Koos et al, 2004; Tepper et al, 2004) . MSNs synapse upon the distal dendrites of other MSNs while FSIs form multiple synapses upon MSNs perisomatically to powerfully regulate MSN output (Koos et al, 2004) . The FSI population increases in density laterally through the dorsal striatum (Schlösser et al, 1999; Luk and Sadikot, 2001) , positioning these cells to influence DLS output to a greater extent than DMS output. FSIs and other striatal cell types, like MSNs, express a host of presynaptically localized G i/o -coupled receptors such as the cannabinoid type 1 receptor (CB1) and 5-HT1b, among others (Mathur et al, 2011 (Mathur et al, , 2013 Atwood et al, 2014a, b) . When activated, these receptors dampen neurotransmitter release. As such, EtOH may be acting through one of these receptors to dampen GABA release onto MSNs. To examine this possible mechanism of action of EtOH on the depression of inhibitory synapses on DLS MSNs, we use whole-cell patch-clamp electrophysiology and optogenetics to isolate potential EtOH effects at either MSN-MSN or FSI-MSN synapses. We show that EtOH induces LTD at MSN and FSI inputs onto MSNs, and that the powerfully inhibitory FSI-MSN synapse is depressed through activation of a presynaptic delta opioid receptor (DOR). Further, we identify adenylyl cyclase/cAMP as the signaling pathway responsible for this novel form of EtOH-induced synaptic plasticity.
METHODS
All experiments were performed in accordance with the United States Public Health Service Guide for Care and Use of Laboratory and were approved by the Institutional Animal Care and Use Committee at the University of Maryland, Baltimore and the National Institute on Alcohol Abuse and Alcoholism. Mice were housed with littermates (2-5 per cage) under a 12-h light/dark cycle (lights on at 0700 hours, off at 1900 hours) with ad libitum access to food and water.
Viral-Mediated Channelrhodopsin (ChR2) Expression
To virally express ChR2 selectively in PV-containing FSIs or MSNs in the DLS, 42-month old Pvalb-cre or RGS9-cre (C57BL/6 background) transgenic mice, respectively, were stereotaxically injected with an AAV vector under an EF1a promoter containing a DIO-ChR2-mCherry or eYFP construct flanked by loxP sites (AAV-flox-DIO-ChR2-mCherry/ eYFP) at a volume of 400 nl and a rate of 20 nl/min into the DLS (AP +0.6 mm, ML ± 2.25 mm, DV − 2.4 mm from bregma), following our previously described methods (Mathur et al, 2013) . To target FSIs for ChR2 expression and record from direct (MSN D ) or putative indirect (MSN ID ) MSNs, Pvalb-cre Drd1a-tdTomato mice were injected with the same viral construct. Animals recovered for a minimum of 3 weeks before brains were sliced for electrophysiology experiments.
Brain Slice Preparation
At least 3 weeks post surgery, animals were anesthetized with isoflurane and brains were dissected out and submerged in 95% oxygen, 5% carbon dioxide (carbogen)-bubbled ice cold cutting solution (194 mM sucrose, 30 mM NaCl, 4.5 mM KCl, 1 mM MgCl 2 , 26 mM NaHCO 3 , 1.2 mM NaH 2 PO 4 , and 10 mM D-glucose). Brains were sliced coronally at 250 μm with a vibratome (Leica VT 1200) and stored in carbogenbubbled artificial cerebrospinal fluid (aCSF; 124 mM NaCl, 4.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 26 mM NaHCO 3 , 1.2 mM NaH 2 PO 4 , and 10 mM D-glucose). Sections were incubated at 32.4°C for 30 min before they were removed and stored at room temperature until electrophysiological recordings were performed. Before recording, slices were hemisected and were constantly perfused with carbogenbubbled aCSF (29-31°C) via a gravity perfusion system throughout the experiment.
Whole-Cell Voltage-Clamp Recordings
Injection sites of ChR2-mCherry/eYFP into the DLS were visualized through the epifluorescent light path using a mercury bulb lamp (X-Cite series 120Q). Whole-cell recordings were made from DLS MSNs receiving inputs from ChR2 infected cells as described previously (Mathur et al, 2013) . Optically evoked IPSCs (oIPSC) were recorded using borosilicate glass pipettes with resistances in the 2-5 MΩ range. Pipettes were pulled on a Flaming Brown micropipette puller (Sutter Instruments) and filled with a CsCl-based internal solution (150 mM CsCl, 10 mM HEPES, 2 mM MgCl 2 , 0.3 mM Na-GTP, 5 mM QX-314, 3 mM Mg-ATP, and 0.2 mM BAPTA) with osmolarity ranging from 305 to 310 mOsm at a pH of 7.3. oIPSCs were evoked with blue light (473 nm) using epifluorescent LED field illumination (Lumen Dynamics, XLED1). Blue light-evoked test pulses were delivered every 20 s with a pulse duration of 2-4 ms. Blue light intensity was adjusted to record oIPSCs with an average amplitude of 600 pA. Ultraviolet light (370 nm, pulse width of 4 ms) was used to photo-uncage bath-applied caged GABA (CNB-GABA, 50 μM) to measure uncaged IPSCs (uIPSC). Electrically evoked IPSCs (eIPSC) were induced using a concentric bipolar stimulating electrode (World Precision Instruments) located locally in the DLS approximately 100 μm from the recorded neuron. eIPSCs were recorded with AP5 (50 μM) and NBQX (5 μM) present in the bath. MSNs were voltage clamped at − 60 mV using a MultiClamp 700B amplifier (Molecular Devices) and recordings were filtered at 2 kHz and digitized at 10 kHz. Clampex 10.4.1.4 software (Molecular Devices) was used for data acquisition. Cells were discarded from analysis if series resistance changed by more than 15% throughout the course of the experiment.
Statistical Analysis
Mean IPSC amplitudes were measured in Clampfit 10.4.1.4 and analyzed using GraphPad Prism 6.01. IPSC amplitudes were averaged per minute and expressed as a percent change from baseline measurements. Average baseline IPSC amplitudes and amplitudes in the final 5 min of recording were compared using a two-tailed paired t test. Changes in IPSC amplitudes between experiments were analyzed using a two-tailed unpaired t test.
Drugs
EtOH, SrCl 2 and GDP-β-S were purchased from SigmaAldrich. Cell-impermeant BAPTA tetracesium salt (molecular weight of 1004.03) and CNB-GABA were purchased from Invitrogen. All other drugs were purchased from Tocris Bioscience.
RESULTS

EtOH Depresses MSN-and FSI-MSN Synapses
The effect of EtOH on MSN-and FSI-MSN synaptic transmission was tested by measuring oIPSC amplitudes during and after 10 min acute exposure to 50 mM EtOH, a concentration of EtOH that correlates to a blood alcohol concentration (BAC) of 230 mg/dl in humans. This BAC is consistent with what late-stage alcoholics achieve (Brick and Erickson, 2009) . EtOH depressed oIPSC amplitude of MSN inputs onto MSNs (MSN-MSN) to 75.69 ± 7.03% of baseline (t = 4.06, df = 4, p = 0.02, Figure 1a ) in 5 out of 5 cells recorded. FSI inputs onto MSNs were depressed to 70.79 ± 5.733% of baseline following EtOH application (t = 5.1, df = 18, po0.001, Figure 1b ). EtOH-induced depression at this synapse was not due to decreased sensitivity of ChR2 to blue light during the 30 min experiment, as the amplitude of FSI-MSN oIPSCs was stable across 30 min of recording in the absence of EtOH ( (Figure 1f ), indicating EtOH-LTD is not pathway specific. The variation in the timing of onset of EtOH-LTD that occurs between FSI-MSN D and FSI-MSNs ID could occur due to the percentage of cells in each group that respond to the EtOH application. Alternatively, this difference may be a function of the Pvalb-cre Drd1a-tdTomato genotype. Because FSIs are the sole source of perisomatic synapses on MSNs (Koos et al, 2004; Tepper et al, 2004) , they provide the most powerful inhibitory influence of all sources of GABA onto MSNs and, thus, are positioned to play a large role in EtOH effects on the disinhibition of the DLS. As such, we henceforth concentrated on elucidating the mechanism of EtOH-LTD at the FSI-MSN synapse.
FSI-MSN EtOH-LTD is Presynaptically Expressed
LTD of inhibitory synapses onto MSNs that is induced at a hyperpolarized or 'downstate' membrane voltage of − 80 mV (iLTD) is present at FSI-MSN synapses and occurs through activation of presynaptically localized CB1 (Mathur et al, 2013) . To test if EtOH-LTD at the FSI-MSN synapse is presynaptically expressed and, therefore, mutually occlusive with eCB-LTD, low frequency electrical stimulation (LFS, 1 Hz, 80 pulses) was locally delivered while voltage clamping MSNs at − 80 mV in the presence or absence of EtOH. LFS depressed the FSI-MSN synapse, consistent with our previous findings (Mathur et al, 2013 ; oIPSC amplitude 79.17 ± 6.94% of baseline, t = 3.00, df = 5, p = 0.03). Application of 50 mM EtOH following iLTD induction did not further depress the synapse (iLTD amplitude = 79.17 ± 6.94% of baseline compared with EtOH-LTD amplitude = 80.38 ± 9.49% of baseline, t = 0.42, df = 5, p = 0.69, Figure 2a) . Additionally, induction of iLTD following the generation of EtOH-LTD did not further depress the synapse (EtOH-LTD amplitude = 89.02 ± 5.73% of baseline compared with iLTD amplitude = 83.70 ± 6.82%, t = 1.08, df = 5, p = 0.33, Figure 2b ).
To further assess whether FSI-MSN EtOH-LTD is expressed pre-or postsynaptically, we replaced CaCl 2 in the aCSF with 2 mM SrCl 2 to enable circuit-specific-asynchronous transmitter release. Changes in optically elicited Sr 2+ -enabled asynchronous IPSC (osIPSC) event frequency and amplitude were measured in the presence of EtOH (Choi and Lovinger, 1997) . EtOH increased inter-event interval (IEI; 149.7 ± 13.06 ms in EtOH compared with control: 110.2 ± 7.47 ms, t = 4.11, df = 8, p = 0.003) but had no effect on event amplitude (EtOH: 23.93 ± 6.0 pA compared with control: 27.27 ± 7.7 pA, t = 1.26, df = 7, p = 0.25, Figure 2c ), further suggesting EtOH-LTD is expressed presynaptically. We next tested if EtOH-LTD is caused by postsynaptic Ca 2+ -mediated processes that could result in either GABA A endocytosis or the production of a retrograde transmitter (Della Rocca et al, 1999; Gerdeman et al, 2002) by loading the postsynaptic cell with cell-impermeable BAPTA (20 mM). BAPTA loading did not block EtOH-LTD (83.16 ± 6.3% of baseline, t = 2.67, df = 12, p = 0.02, Figure 2d ). To isolate potential changes on the postsynaptic side, we elicited IPSCs by photo-uncaging the caged-GABA compound CNB-GABA (50 μM). Photo-uIPSC amplitudes during EtOH application did not depress in the presence of EtOH (uIPSC amplitude = 103.6 ± 3.91%, t = 0.93, df = 5, p = 0.40), unlike eIPSC amplitudes in the same cell (eIPSC amplitude = 70.47 ± 6.21%, t = 4.76, df = 5, p = 0.01, Figure 2e ), further suggesting EtOH-LTD is presynaptically expressed. Electrically evoked IPSC amplitude depression following EtOH application was significantly different from uIPSC amplitude (uIPSC amplitude 103.6 ± 3.91% compared with eIPSC amplitude 70.47 ± 6.21%, t = 4.52, df = 10, p = 0.001). Finally, to test if contributions from postsynaptic G-protein-coupled receptors underlie FSI-MSN EtOH-LTD, the G-protein receptor inhibitor GDP-β-S (500 μM) was included in the internal pipette solution. EtOH application in the presence of GDP-β-S depressed the synapse (oIPSC amplitude = 71.20 ± 6.67% of baseline, t = 4.32, df = 5, p = 0.01, Figure 2f ), indicating that contributions of postsynaptic G-protein-coupled receptors are not necessary for EtOH-LTD.
FSI-MSN EtOH-LTD is DOR Dependent
Our data show that EtOH-LTD is mutually occlusive with iLTD in the DLS, which is dependent on activation of the presynaptically localized, G i/o -coupled CB1 (Mathur et al, 2013) . To investigate if EtOH-LTD acts through this same CB1-dependent pathway, we pre-incubated slices in the CB1 receptor antagonist AM251 (5 μM) for at least 35 min before exposing EtOH to the slice. EtOH application in the presence of AM251 depressed both MSN and FSI transmission onto MSNs (MSN-MSN: oIPSC amplitude = 71.31 ± 7.31% of baseline, t = 3.81, df = 4, p = 0.02; FSI-MSN: oIPSC amplitude = 66.90 ± 7.46% of baseline, t = 4.44, df = 3, p = 0.021), indicating EtOH-LTD is CB1 independent.
Like CB1-dependent LTD, several other forms of LTD are known to depend on activation of a presynaptically localized G i/o -coupled receptor (Atwood et al, 2014b) . Given the known interactions between EtOH and the opioid system (Volpicelli et al, 1992; Drews and Zimmer, 2010) , and that activation of these G i/o -coupled opioid receptors is capable of inducing striatal presynaptic LTD (Atwood et al, 2014a) , we next assessed whether EtOH-LTD occurs in an opioid receptor-dependent fashion. MSN-MSN EtOH-LTD was not eliminated in the presence of naloxone, a pan opioid receptor antagonist (oIPSC amplitude = 80.03 ± 6.94% of baseline, t = 2.88, df = 6, p = 0.03, Figure 3a) . However, FSI-MSN EtOH-LTD was eliminated in the presence of naloxone (5 μM, oIPSC amplitude = 97.87 ± 2.99%, t = 0.71, df = 6, p = 0.50, Figure 3b ) and was significantly different from control EtOH-induced depression of oIPSC amplitude (EtOH-LTD oIPSC amplitude = 67.51 ± 7.78% compared with naloxone oIPSC amplitude 97.87 ± 2.99%, t = 3.28, df = 14, p = 0.01), indicating EtOH-LTD at the MSN-and FSI-MSN synapses are mechanistically distinct.
To determine the specific opioid receptor involved in FSI-MSN EtOH-LTD, we then incubated slices in the DORspecific antagonist naltrindole (1 μM) before applying EtOH. Naltrindole blocked EtOH-LTD at the FSI-MSN synapse (oIPSC amplitude = 97.65 ± 7.32% of baseline, t = 0.32, df = 7, p = 0.76, Figure 3c) , and the EtOH effect in this condition differed from control EtOH-LTD (control EtOH-LTD oIPSC amplitude 66.67 ± 6.54%, t = 3.16, df = 14, p = 0.01). To determine if this form of LTD is labile or static (Atwood et al, 2014b) , we applied naltrindole (1 μM) to slices 15 min after EtOH washout (Figure 3d ). EtOH-LTD did not return to baseline in the presence of naltrindole, suggesting this form of LTD is static (oIPSC following EtOH application = 75.95 ±3.07% of baseline, t = 6.23, df = 5, p = 0.02; oIPSC in naltrindole = 63.58 ± 9.91% of baseline, t = 3.58, df = 5, p = 0.02). Because EtOH-LTD appears to be presynaptically expressed, and DOR, like CB1, may reside presynaptically, we hypothesized that DOR resides on the FSI terminal. Supporting this idea, application of the DOR agonist DPDPE (500 nM) depressed the FSI-MSN synapse (oIPSC amplitude = 81.98 ± 3.49% of baseline, t = 5.16, df = 11, p = 0.0003) but the mu opioid receptor agonist, DAMGO (2 μM) did not (oIPSC amplitude = 99.50 ± 7.50% of baseline, t = 0.12, df = 5, p = 0.91, Figure 3e ). Using PV-cre Drd1a-tdTomato mice we determined that DPDPE-induced LTD of oIPSC amplitude at the FSI-MSN synapse is not pathway specific; DPDPE depressed the FSI-MSN D synapse to 66.46 ± 8.36% of baseline (t = 4.01, df = 8, p = 0.004) and depressed the FSI-MSN ID synapse to 79.19 ± 5.45% of baseline (t = 3.82, df = 6, p = 0.01, Figure 3f ). These data suggest that DOR is present on FSI terminals impinging upon both MSN D and MSN ID.
DOR-Mediated Depression of the FSI-MSN Synapse is Adenylyl Cyclase Dependent
DOR is a G i/o -coupled receptor that is known to decrease cAMP production when activated (Al-Hasani and Bruchas, 2011 ). Therefore, we tested the prediction that activating adenylyl cyclase, the enzyme responsible for catalyzing the conversion of ATP to cAMP, will block DOR-induced LTD. Pre-incubating slices in 15 μM forskolin, an activator of adenylyl cyclase, for at least 20 min before DPDPE application indeed blocked DOR-induced LTD of oIPSC amplitude (oIPSC amplitude 97.04 ± 5.10% of baseline, t = 0.58, df = 7, p = 0.58, Figure 3g ) as compared with control aCSF (oIPSC amplitude 67.04 ± 10.65% of baseline, t = 3.10, df = 7, p = 0.02). To test the downstream target of adenylyl cyclase, we incubated slices in the cell-permeable cAMP analog, 8-bromo-cAMP (160 μM) and measured oIPSC amplitude following DPDPE application. We found that DPDPE did not decrease oIPSC amplitude in the presence of 8-bromocAMP (95.77 ± 9.67%, t = 0.44, df = 10, p = 0.67, Figure 3h ), as it did in control aCSF (68.67 ± 5.51%, t = 5.68, df = 7, p = 0.001), which suggests that DPDPE-induced LTD occurs through a cAMP-dependent signaling pathway. 8-bromocAMP blockade of DPDPE-induced LTD was significantly different than control LTD (t = 2.20, df = 17, p = 0.04).
DOR is Located Presynaptically on FSIs
DOR is known to co-localize with a subset of GABAergic neurons in mouse dorsal striatum (Scherrer et al, 2006) , a finding that suggests co-localization onto a GABAergic interneuron population as opposed to the principal GABAergic MSN. These findings are consistent with our results that EtOH-LTD is presynaptically expressed and mediated through DOR activation. Thus, we tested the prediction that DOR is located on presynaptic FSI terminals by measuring changes in asynchronous osIPSC amplitude and event frequency in the presence of DPDPE. DPDPE application increased the IEI of osIPSC events (baseline IEI 95.09 ± 2.81 ms; post-DPDPE IEI 130.1 ± 7.60 ms, t = 4.35, df = 15, p = 0.001, Figure 4a ). DPDPE application also depressed osIPSC amplitude (baseline amplitude 20.61 ± 1.50 pA; post-DPDPE amplitude 16.47 ± 1.90 pA, t = 3.65, df = 14, p = 0.003, Figure 4a ). These data suggest that DPDPE lowers GABA release probability from FSIs. In addition, there is either a possible postsynaptic effect of DPDPE on GABA A receptor availability or the reduction in probability of release reduces synchronous spontaneous event probability, which would in turn reduce event amplitude. To rule out contributions of postsynaptic DOR to FSI-MSN DPDPE-induced LTD, GDP-β-S (500 μM) was included in the internal pipette solution to disrupt G protein signaling in the postsynaptic cell. DPDPE application reliably depressed oIPSC amplitudes with GDP-β-S present (oIPSC amplitude = 70.08 ± 10.75% of baseline, t = 2.78, df = 8, p = 0.02, Figure 4b) . Finally, to test if 
DISCUSSION
The data presented here describe a novel, EtOH-induced, DOR-dependent LTD of FSI-MSN synaptic transmission that, in conjunction with EtOH-LTD at MSN-MSN synapses, likely contributes to the increase in DLS output that occurs following EtOH exposure. We show that DORinduced LTD at the FSI-MSN synapse occurs through the canonical adenylyl cyclase/cAMP pathway downstream of DOR activation ( Figure 5 ). The discovery that DOR is positioned to regulate FSI-MSN synaptic transmission implicates the opioid system in the physiological expression of habit learning (Wassum et al, 2009 ) and other striataldependent behaviors. Finally, EtOH also reliably depresses the MSN-MSN synapse. Although additional work is necessary to unveil the mechanism underlying this effect, our data thus far suggest a presynaptic locus of expression of this form of LTD that functions independently of both CB1 and opioid receptors.
We demonstrate that EtOH-LTD is mutually occlusive with a form of eCB-LTD at the FSI-MSN synapse but is not mediated through CB1 receptors ( Figure 5 ). These findings are in line with previous work demonstrating that EtOH blocks eCB-mediated disinhibition of the DLS in a CB1-independent manner (Adermark and Lovinger 2009; Clarke and Adermark, 2010 (Iremonger and Bains, 2009; Wamsteeker Cusulin et al, 2013) and MSNs ID contain pre-proenkephalin, the precursor for the most efficacious endogenous agonist of DOR (Gerfen et al, 1990; Surmeier et al, 1996) . However, we found that EtOH depresses FSI transmission onto both MSNs D and MSNs ID and this depression is not eliminated with a postsynaptic Ca 2+ chelator. Therefore, it is unlikely that EtOH induces release of a retrograde opioid signal from postsynaptic MSNs. It is possible that another source providing the endogenous DOR agonist is recruited by EtOH. One candidate is the external segment of the globus pallidus. This structure sends GABAergic projections to both MSNs and FSIs in the dorsal striatum (Bevan et al, 1998; Mallet et al, 2012; Mastro et al, 2014) and these projections express pre-proenkephalin (Mallet et al, 2012) . Given that the variability in the induction of EtOH-LTD at the FSI-MSN synapse is not explained by differences in FSI-MSN D and FSI-MSN ID pathways, and that DPDPE application consistently induces FSI-MSN synaptic depression, the heterogeneous expression of FSI-MSN EtOH-LTD may be due to the variability in the EtOH-induced release of the endogenous DOR agonist.
While our results specifically describe the effects of EtOH on GABAergic transmission in the DLS, Wilcox et al (2014) report that acute EtOH exposure and chronic EtOH drinking induces a higher frequency of basal miniature IPSC (mIPSC) events in the DMS, and a lower frequency of mIPSC events in the DLS. This DMS to DLS response difference may be explained by the higher expression of FSIs in the DLS (Schlösser et al, 1999; Luk and Sadikot, 2001) , as the majority of mIPSCs onto MSNs arise from FSIs (Koos et al, 2004) . Taking the DOR-mediated depression of FSI-MSN synapses in the DLS following acute EtOH exposure together with the reported increase in GABA transmission onto DMS MSNs, EtOH appears to shape the global output of the striatum by modulating GABA synapses. Indeed, the importance of the presently described mechanism in drinking is supported by the findings of Nielsen et al (2012) that show striatal DOR blockade decreases repeated EtOH intake in rats, while activating striatal DOR increases consumption. In light of this, additional studies are necessary to understand the effects of EtOH on DOR-mediated depression of the FSI-MSN synapse in the DLS following a chronic drinking paradigm.
